178 related articles for article (PubMed ID: 21255943)
1. Radiotherapy breast boost with reduced whole-breast dose is associated with improved cosmesis: the results of a comprehensive assessment from the St. George and Wollongong randomized breast boost trial.
Hau E; Browne LH; Khanna S; Cail S; Cert G; Chin Y; Clark C; Inder S; Szwajcer A; Graham PH
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):682-9. PubMed ID: 21255943
[TBL] [Abstract][Full Text] [Related]
2. Proposal for a gold standard for cosmetic evaluation after breast conserving therapy: Results from the St George and Wollongong Breast Boost trial.
Merie R; Browne L; Cardoso JS; Cardoso MJ; Chin Y; Clark C; Graham P; Szwajcer A; Hau E
J Med Imaging Radiat Oncol; 2017 Dec; 61(6):819-825. PubMed ID: 28834326
[TBL] [Abstract][Full Text] [Related]
3. A cosmetic evaluation of breast cancer treatment: a randomized study of radiotherapy boost technique.
Vass S; Bairati I
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1274-82. PubMed ID: 16029782
[TBL] [Abstract][Full Text] [Related]
4. Electron and high-dose-rate brachytherapy boost in the conservative treatment of stage I-II breast cancer first results of the randomized Budapest boost trial.
Polgár C; Fodor J; Orosz Z; Major T; Takácsi-Nagy Z; Mangel LC; Sulyok Z; Somogyi A; Kásler M; Németh G
Strahlenther Onkol; 2002 Nov; 178(11):615-23. PubMed ID: 12426672
[TBL] [Abstract][Full Text] [Related]
5. Accelerated hypofractionated adjuvant whole breast radiotherapy with concomitant photon boost after conserving surgery for early stage breast cancer: a prospective evaluation on 463 patients.
Cante D; Rosa La Porta M; Casanova-Borca V; Sciacero P; Girelli G; Pasquino M; Franco P; Ozzello F
Breast J; 2011; 17(6):586-93. PubMed ID: 21951485
[TBL] [Abstract][Full Text] [Related]
6. The influence of the boost in breast-conserving therapy on cosmetic outcome in the EORTC "boost versus no boost" trial. EORTC Radiotherapy and Breast Cancer Cooperative Groups. European Organization for Research and Treatment of Cancer.
Vrieling C; Collette L; Fourquet A; Hoogenraad WJ; Horiot JC; Jager JJ; Pierart M; Poortmans PM; Struikmans H; Van der Hulst M; Van der Schueren E; Bartelink H
Int J Radiat Oncol Biol Phys; 1999 Oct; 45(3):677-85. PubMed ID: 10524422
[TBL] [Abstract][Full Text] [Related]
7. The addition of a boost dose on the primary tumour bed after lumpectomy in breast conserving treatment for breast cancer. A summary of the results of EORTC 22881-10882 "boost versus no boost" trial.
Poortmans PM; Collette L; Bartelink H; Struikmans H; Van den Bogaert WF; Fourquet A; Jager JJ; Hoogenraad W; Müller RP; Dubois JB; Bolla M; Van Der Hulst M; Wárlám-Rodenhuis CC; Pierart M; Horiot JC;
Cancer Radiother; 2008 Nov; 12(6-7):565-70. PubMed ID: 18760649
[TBL] [Abstract][Full Text] [Related]
8. Phase 2 trial of accelerated, hypofractionated whole-breast irradiation of 39 Gy in 13 fractions followed by a tumor bed boost sequentially delivering 9 Gy in 3 fractions in early-stage breast cancer.
Kim JY; Jung SY; Lee S; Kang HS; Lee ES; Park IH; Lee KS; Ro J; Lee NK; Shin KH
Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):1037-42. PubMed ID: 24267970
[TBL] [Abstract][Full Text] [Related]
9. High-dose-rate brachytherapy alone versus whole breast radiotherapy with or without tumor bed boost after breast-conserving surgery: seven-year results of a comparative study.
Polgár C; Major T; Fodor J; Németh G; Orosz Z; Sulyok Z; Udvarhelyi N; Somogyi A; Takácsi-Nagy Z; Lövey K; Agoston P; Kásler M
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1173-81. PubMed ID: 15519789
[TBL] [Abstract][Full Text] [Related]
10. Breast irradiation causes pallor in the nipple-areolar complex in women with Celtic skin type (result from the St. George and Wollongong randomised breast boost trial).
Lee YY; Hau E; Browne LH; Chin Y; Lee J; Szwajcer A; Cail S; Nolan DN; Graham PH
J Med Imaging Radiat Oncol; 2014 Apr; 58(2):229-36. PubMed ID: 24456128
[TBL] [Abstract][Full Text] [Related]
11. Cosmesis, late sequelae and local control after breast-conserving therapy: influence of type of tumour bed boost and adjuvant chemotherapy.
Budrukkar AN; Sarin R; Shrivastava SK; Deshpande DD; Dinshaw KA
Clin Oncol (R Coll Radiol); 2007 Oct; 19(8):596-603. PubMed ID: 17706403
[TBL] [Abstract][Full Text] [Related]
12. Intraoperative radiotherapy given as a boost for early breast cancer: long-term clinical and cosmetic results.
Lemanski C; Azria D; Thezenas S; Gutowski M; Saint-Aubert B; Rouanet P; Fenoglietto P; Ailleres N; Dubois JB
Int J Radiat Oncol Biol Phys; 2006 Apr; 64(5):1410-5. PubMed ID: 16442241
[TBL] [Abstract][Full Text] [Related]
13. Local recurrence rates in breast cancer patients treated with intraoperative electron-boost radiotherapy versus postoperative external-beam electron-boost irradiation. A sequential intervention study.
Reitsamer R; Peintinger F; Kopp M; Menzel C; Kogelnik HD; Sedlmayer F
Strahlenther Onkol; 2004 Jan; 180(1):38-44. PubMed ID: 14704843
[TBL] [Abstract][Full Text] [Related]
14. 5-year results of pulsed dose rate brachytherapy applied as a boost after breast-conserving therapy in patients at high risk for local recurrence from breast cancer.
Harms W; Krempien R; Hensley FW; Berns C; Fritz P; Wannenmacher M
Strahlenther Onkol; 2002 Nov; 178(11):607-14. PubMed ID: 12426671
[TBL] [Abstract][Full Text] [Related]
15. Skin toxicity and cosmesis after hypofractionated whole breast irradiation for early breast cancer.
Saksornchai K; Rojpornpradit P; Shotelersak K; Lertbutsayanukul C; Chakkabat C; Raiyawa T
J Med Assoc Thai; 2012 Feb; 95(2):229-40. PubMed ID: 22435254
[TBL] [Abstract][Full Text] [Related]
16. Analysis of treatment efficacy, cosmesis, and toxicity using the MammoSite breast brachytherapy catheter to deliver accelerated partial-breast irradiation: the william beaumont hospital experience.
Chao KK; Vicini FA; Wallace M; Mitchell C; Chen P; Ghilezan M; Gilbert S; Kunzman J; Benitez P; Martinez A
Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):32-40. PubMed ID: 17467920
[TBL] [Abstract][Full Text] [Related]
17. Long-term toxicity of an intraoperative radiotherapy boost using low energy X-rays during breast-conserving surgery.
Kraus-Tiefenbacher U; Bauer L; Scheda A; Fleckenstein K; Keller A; Herskind C; Steil V; Melchert F; Wenz F
Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):377-81. PubMed ID: 16887294
[TBL] [Abstract][Full Text] [Related]
18. The cosmetic outcome in early breast cancer treated with breast conservation.
Al-Ghazal SK; Blamey RW; Stewart J; Morgan AA
Eur J Surg Oncol; 1999 Dec; 25(6):566-70. PubMed ID: 10556000
[TBL] [Abstract][Full Text] [Related]
19. Validation of the methods of cosmetic assessment after breast-conserving therapy in the EORTC "boost versus no boost" trial. EORTC Radiotherapy and Breast Cancer Cooperative Groups. European Organization for Research and Treatment of Cancer.
Vrieling C; Collette L; Bartelink E; Borger JH; Brenninkmeyer SJ; Horiot JC; Pierart M; Poortmans PM; Struikmans H; Van der Schueren E; Van Dongen JA; Van Limbergen E; Bartelink H
Int J Radiat Oncol Biol Phys; 1999 Oct; 45(3):667-76. PubMed ID: 10524421
[TBL] [Abstract][Full Text] [Related]
20. Breast-conserving treatment with partial or whole breast irradiation for low-risk invasive breast carcinoma--5-year results of a randomized trial.
Polgár C; Fodor J; Major T; Németh G; Lövey K; Orosz Z; Sulyok Z; Takácsi-Nagy Z; Kásler M
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):694-702. PubMed ID: 17531400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
